Your browser doesn't support javascript.
loading
TAS-102 plus bevacizumab for patients with metastatic colorectal cancer refractory to standard therapies (C-TASK FORCE): an investigator-initiated, open-label, single-arm, multicentre, phase 1/2 study.
Kuboki, Yasutoshi; Nishina, Tomohiro; Shinozaki, Eiji; Yamazaki, Kentaro; Shitara, Kohei; Okamoto, Wataru; Kajiwara, Takeshi; Matsumoto, Toshihiko; Tsushima, Takahiro; Mochizuki, Nobuo; Nomura, Shogo; Doi, Toshihiko; Sato, Akihiro; Ohtsu, Atsushi; Yoshino, Takayuki.
Afiliação
  • Kuboki Y; National Cancer Center Hospital East, Kashiwa, Japan.
  • Nishina T; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
  • Shinozaki E; The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Yamazaki K; Shizuoka Cancer Center, Shizuoka, Japan.
  • Shitara K; National Cancer Center Hospital East, Kashiwa, Japan.
  • Okamoto W; National Cancer Center Hospital East, Kashiwa, Japan.
  • Kajiwara T; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
  • Matsumoto T; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
  • Tsushima T; Shizuoka Cancer Center, Shizuoka, Japan.
  • Mochizuki N; National Cancer Center Hospital East, Kashiwa, Japan.
  • Nomura S; National Cancer Center Hospital East, Kashiwa, Japan.
  • Doi T; National Cancer Center Hospital East, Kashiwa, Japan.
  • Sato A; National Cancer Center Hospital East, Kashiwa, Japan.
  • Ohtsu A; National Cancer Center Hospital East, Kashiwa, Japan.
  • Yoshino T; National Cancer Center Hospital East, Kashiwa, Japan. Electronic address: tyoshino@east.ncc.go.jp.
Lancet Oncol ; 18(9): 1172-1181, 2017 09.
Article em En | MEDLINE | ID: mdl-28760399
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Uracila / Neoplasias Colorretais / Adenocarcinoma / Trifluridina / Inibidores da Angiogênese / Bevacizumab Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Uracila / Neoplasias Colorretais / Adenocarcinoma / Trifluridina / Inibidores da Angiogênese / Bevacizumab Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão